BIOCRYST PHARMACEUTICALS INC short interest in 2023
In 2023, BIOCRYST PHARMACEUTICALS INC's disclosed short interest ran from 14.00% of shares outstanding on 13 Jan 2023 to 14.69% on 29 Dec 2023, a change of +0.69 percentage points. The year's high was 23.32% on 13 Oct 2023 and its low 14.00% on 13 Jan 2023, averaging 17.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.02 days on 13 Oct 2023. Full history: BIOCRYST PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 14.00% (13 Jan 2023)
- End of year
- 14.69% (29 Dec 2023)
- Change
- +0.69 pp
- High
- 23.32% (13 Oct 2023)
- Low
- 14.00% (13 Jan 2023)
- Average
- 17.60%
- Highest days to cover
- 20.02 (13 Oct 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 14.00% | 6.06 | results (8-K) |
| 31 Jan 2023 | 14.16% | 12.58 | |
| 15 Feb 2023 | 14.32% | 13.71 | |
| 28 Feb 2023 | 15.64% | 6.20 | results (8-K), 10-K filed |
| 15 Mar 2023 | 16.35% | 9.37 | |
| 31 Mar 2023 | 16.57% | 13.16 | |
| 14 Apr 2023 | 16.11% | 12.76 | |
| 28 Apr 2023 | 16.52% | 9.54 | |
| 15 May 2023 | 17.10% | 10.81 | results (8-K), 10-Q filed |
| 31 May 2023 | 18.83% | 13.90 | |
| 15 Jun 2023 | 18.78% | 18.19 | |
| 30 Jun 2023 | 19.79% | 10.75 | |
| 14 Jul 2023 | 19.97% | 18.11 | |
| 31 Jul 2023 | 20.58% | 16.29 | |
| 15 Aug 2023 | 21.14% | 12.27 | results (8-K), 10-Q filed |
| 31 Aug 2023 | 21.80% | 19.59 | |
| 15 Sep 2023 | 22.43% | 16.53 | |
| 29 Sep 2023 | 22.37% | 16.79 | |
| 13 Oct 2023 | 23.32% | 20.02 | |
| 31 Oct 2023 | 14.71% | 7.49 | |
| 15 Nov 2023 | 14.39% | 8.31 | results (8-K), 10-Q filed |
| 30 Nov 2023 | 14.34% | 12.25 | |
| 15 Dec 2023 | 14.54% | 3.99 | |
| 29 Dec 2023 | 14.69% | 10.40 |
See also: BIOCRYST PHARMACEUTICALS INC's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.